Provided by Tiger Trade Technology Pte. Ltd.

AngioDynamics

16.13
+0.28001.77%
Post-market: 16.130.00000.00%19:30 EDT
Volume:358.53K
Turnover:5.75M
Market Cap:664.55M
PE:-18.23
High:16.22
Open:15.80
Low:15.63
Close:15.85
52wk High:16.29
52wk Low:9.39
Shares:41.20M
Float Shares:36.08M
Volume Ratio:1.50
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8848
EPS(LYR):-0.8848
ROE:-20.77%
ROA:-5.13%
PB:3.89
PE(LYR):-18.23

Loading ...

AngioDynamics reports durable 2-year NanoKnife outcomes in PRESERVE prostate cancer trial

Reuters
·
May 13

AngioDynamics Announces Two-Year Preserve Trial Data Demonstrating Durable Nanoknife Ire System Outcomes in Intermediate-Risk Prostate Cancer

THOMSON REUTERS
·
May 13

AngioDynamics Files Patent Suit to Protect Thrombectomy Technology

TIPRANKS
·
Apr 24

BRIEF-Angiodynamics Files Patent Infringement Lawsuit Against Endovascular Engineering On April 23, 2026

Reuters
·
Apr 24

AngioDynamics - Files Patent Infringement Lawsuit Against Endovascular Engineering on April 23, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 24

AngioDynamics sues Endovascular Engineering over alleged Hēlo Thrombectomy System patent infringement

Reuters
·
Apr 24

AngioDynamics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 06

AngioDynamics initiated with a Buy at Freedom Broker

TIPRANKS
·
Apr 06

AngioDynamics price target lowered to $16 from $18 at Canaccord

TIPRANKS
·
Apr 06

Canaccord Genuity Remains a Buy on AngioDynamics (ANGO)

TIPRANKS
·
Apr 06

AngioDynamics Earnings Call Highlights Med Tech Momentum

TIPRANKS
·
Apr 06

AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance

TIPRANKS
·
Apr 02

AngioDynamics Lifts Outlook Despite Widening 3Q Loss

Dow Jones
·
Apr 02

AngioDynamics Q3 revenue beats estimates on Med Tech strength, raises outlook

Reuters
·
Apr 02

AngioDynamics Q3 Adj. EPS $(0.07) Beats $(0.11) Estimate, Sales $78.423M Beat $76.767M Estimate

Benzinga Earnings
·
Apr 02

BRIEF-AngioDynamics Q3 Adjusted EPS USD -0.07

Reuters
·
Apr 02

AngioDynamics Inc - FY2026 Expected Tariff Impact $4.0-$6.0 Mln Included in Guidance

THOMSON REUTERS
·
Apr 02

AngioDynamics Outlook FY Sales USD 313.5-315.5 Million

THOMSON REUTERS
·
Apr 02

AngioDynamics Inc - FY2026 Net Sales Guidance Increased to $313.5-$315.5 Mln

THOMSON REUTERS
·
Apr 02

AngioDynamics Inc FY2026 Shr View $-0.29, REV View $312.9 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Apr 02